{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:22:56Z","timestamp":1791685376427,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.jclinepi.2006.11.006","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T15:05:21Z","timestamp":1176908721000},"page":"812-818","source":"Crossref","is-referenced-by-count":62,"title":["Statin and statin\u2013fibrate use was significantly associated with increased myositis risk in a managed care population"],"prefix":"10.1016","volume":"60","author":[{"given":"David L.","family":"McClure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Valuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morton","family":"Glanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Hokanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2006.11.006_bib1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.jclinepi.2006.11.006_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM200202143460721","article-title":"Cerivastatin and reports of fatal rhabdomyolysis","volume":"46","author":"Staffa","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jclinepi.2006.11.006_bib3","doi-asserted-by":"crossref","unstructured":"McClure DL, Valuck RJ, Glanz M, Hokanson JE. Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present. Pharmacoepidemiol Drug Saf 2007;16:132\u201343.","DOI":"10.1002\/pds.1341"},{"key":"10.1016\/j.jclinepi.2006.11.006_bib4","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/0002-9149(91)90276-Q","article-title":"Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE)","volume":"68","author":"Sacks","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jclinepi.2006.11.006_bib5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0895-4356(92)90068-X","article-title":"A coronary primary prevention study of Scottish men age 45\u201364 years: trial design","volume":"45","author":"West of Scotland Coronary Prevention Study Group","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2006.11.006_bib6","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S)","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2006.11.006_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0002-9149(99)80133-7","article-title":"Design features and baseline characteristics of the LIPID (Long-term Intervention with Pravastatin in Ischaemic Disease) study: a randomized trial in patients with previous acute myocardial infarction and\/or unstable angina pectoris","volume":"76","author":"The LIPID Study Group","year":"1995","journal-title":"Am J Cardiol"},{"issue":"20","key":"10.1016\/j.jclinepi.2006.11.006_bib8","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jclinepi.2006.11.006_bib9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1053\/euhj.1998.1350","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience","volume":"20","author":"MRC\/BHF Heart Protection Study Collaborative Group","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jclinepi.2006.11.006_bib10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001648-200109000-00017","article-title":"Lipid-lowering drugs and risk of myopathy","volume":"12","author":"Gaist","year":"2001","journal-title":"Epidemiology"},{"key":"10.1016\/j.jclinepi.2006.11.006_bib11","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1592\/phco.22.17.1524.34130","article-title":"Etiology and frequency of rhabdomyolysis","volume":"22","author":"Black","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jclinepi.2006.11.006_bib12","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1001\/jama.292.21.2585","article-title":"Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs","volume":"292","author":"Graham","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jclinepi.2006.11.006_bib13","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.CIR.0000032466.44170.44","article-title":"ACC\/AHA\/NHLBI Clinical Advisory on the use and safety of statins","volume":"106","author":"Pasternak","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jclinepi.2006.11.006_bib14","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/S0022-2828(95)92163-X","article-title":"Differential sensitivity of C2\u2013C12 striated muscle cells to lovastatin and pravastatin","volume":"27","author":"Gadbut","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jclinepi.2006.11.006_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.amjmed.2003.10.033","article-title":"Current overview of statin-induced myopathy","volume":"116","author":"Rosenson","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jclinepi.2006.11.006_bib16","series-title":"Applied logistic regression","author":"Hosmer","year":"2000"},{"issue":"8S","key":"10.1016\/j.jclinepi.2006.11.006_bib17","first-page":"S1","volume":"97","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jclinepi.2006.11.006_bib18","author":"Miller"},{"issue":"3","key":"10.1016\/j.jclinepi.2006.11.006_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1592\/phco.25.3.345.61606","article-title":"Low myopathy rates associated with statins as monotherapy or combination therapy with interacting drugs in a group model health maintenance organization","volume":"25","author":"Shanahan","year":"2005","journal-title":"Pharmacotherapy"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089543560600432X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089543560600432X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T07:17:44Z","timestamp":1556349464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089543560600432X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S089543560600432X"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2006.11.006","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}